Spotlight of the month: Mathys & Squire’s patent practice recommended in latest directories for IAM Patent 1000 and Financial Times’ Leading European Patent Law Firms
Regeneron v Kymab: Supreme Court reins in Regeneron patents
Achieving net-zero carbon emissions with electric vehicles
Managing sensitive information and valuable IP
Tiny AI: the next big thing in intellectual property?
Mathys Matters May 2020
In this edition:
Spotlight of the month: Mathys & Squire and clients featured in article by The Guardian on innovation during the COVID-19 lockdown
What is Tiny AI?
Genomics and public health: A patent attorney’s perspective
Enlarged Board of Appeal issues decision on plant patents
Early case law suggests remittal will remain common
Mathys Matters April 2020
In this edition:
Spotlight of the month: Mathys & Squire ranked in Legallease’s top 20 list of best-rated firms for client service
Advances in recycling and replacing plastics
Tips to help navigate your IP strategy during uncertain times
Fintech innovation: protecting your ideas
EPO case law: can treatment history confer novelty?
EPO/UKIPO deadlines extended
Mathys Matters March 2020
In this edition:
Spotlight of the month: Budget 2020 – a greener future for innovation
The AI chips race is on – what role will IP play?
COVID-19: patents are not incentives for vaccine research
Global research rush spurs COVID-19 patent challenges
Women in scientific innovation: closing the inventor gender gap
COVID-19 update from Mathys & Squire
Mathys Matters February 2020
In this edition:
Spotlight of the month: Innovative brand protection
The role of tech in the future of healthcare
Cell therapy: challenges and perspectives
The AI ‘hype’: how will the world of IP be affected?
CJEU hands down judgment on Sky v SkyKick
Mathys & Squire trade mark team recommended in WTR 1000 2020
Mathys Matters January 2020
In this edition:
Spotlight of the month: IP trends for 2020
IP protection as UK tech sector sees record year of VC funding
EPO Board of Appeal confirms revocation of important CRISPR patent
R&D – how can it help fund your business?
IP protection in fast-moving global markets: medical cannabis & CBD
Mathys & Squire seminar: Developing and implementing a commercially robust IP strategy
Mathys Matters December 2019
In this edition:
Spotlight of the month: A roundup of 2019
JUVE Patent recommends Mathys & Squire in 2020 rankings
Opportunities for IP in drive for healthy chocolate
What the leaked US-UK trade deal documents revealed
IPEC sides with US rival in Shnuggle design dispute
Managing IP’s IP STARS rankings
Mathys Matters November 2019
In this edition:
Spotlight of the month: Debunking food and beverage IP myths
How illegal is stealing trade secrets in the US and UK?
Client Rotolight secures further investment
Are you considering IP in your product development cycle?
Chinese court judgment on SEP royalty dispute (Huawei v Conversant)
Mathys & Squire’s Trends in IP litigation report
Upcoming events
Mathys Matters April 2019
In this edition:
Spotlight of the month: The IoT – why it matters to med-tech